Ortivus AB (publ) develops and commercializes medical technology solutions and e-health for healthcare industry in Sweden and internationally. The company offers MobiMed Monitor that monitor and shares vital signs and ECG; MobiMed ePR, an electronic patient record system for documentation of treatment and events; MobiMed enRoute, a navigation, case management, and mass casualty management; MobiMed FleetCtrl, a a software application that regular controls, checklists, and documentation tailored for seamless fleet management; MobiMed Life, a heart safe solution. It also provides emergency medical services, primary care, and rescue services. The company was founded in 1985 and is headquartered in Danderyd, Sweden. Ortivus AB (publ) is a subsidiary of Ponderus Invest AB.
Frequently asked questions
What sector does Ortivus AB ser. B (ORTI-B) operate in?
Ortivus AB ser. B belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is Ortivus AB ser. B (ORTI-B) current stock price?
As of the latest data, Ortivus AB ser. B stock price is SEK 1.96, with a previous close of SEK 1.96.
What is Ortivus AB ser. B (ORTI-B) current market capitalization?
Ortivus AB ser. B market cap is approximately 170.43 million.
What is Ortivus AB ser. B (ORTI-B) Earnings Per Share (EPS)?
The trailing EPS is -SEK 0.39.
What is Ortivus AB ser. B (ORTI-B) EBITDA?
Ortivus AB ser. B EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 1.97 million.
Does Ortivus AB ser. B (ORTI-B) pay dividends?
No. Ortivus AB ser. B does not pay a dividend.
What is Ortivus AB ser. B (ORTI-B) beta (volatility) score?
Ortivus AB ser. B has a beta of 0.907, meaning its volatility is roughly in line with the market.
